FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083352 [Registered on: 25/03/2025] Trial Registered Prospectively
Last Modified On: 22/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study to compare the efficacy of Pathyadi Kwath and Rasnadi Kwath in the management of Ardhavbhedak (Migraine) 
Scientific Title of Study   Comparative clinical study to evaluate the efficacy of Pathyadi Kwath and Rasnadi Kwath in the management of Ardhavbhedak w.s.r. to Migraine 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Monika Mittal 
Designation  M.S. Scholar 
Affiliation  Madan Mohan Malviya Government Ayurvedic College, Udaipur 
Address  20, Hardeva Vihar, Beri Wala Bagh, Near Jaipaltan Road, Alwar, Rajasthan (301001)
OPD no. 9 and 10, PG dept. of Shalakya Tantra, Madan Mohan Malviya Government Ayurved College, Ambamata, Udaipur (Rajasthan)
Udaipur
RAJASTHAN
301001
India 
Phone  8949721283  
Fax    
Email  monikamittal1997@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Gulab Chand Bairwa 
Designation  Professor and HOD 
Affiliation  Madan Mohan Malviya Government Ayurvedic College, Udaipur 
Address  PG department of Shalakya Tantra, Madan Mohan Malviya Government Ayurvedic College, Udaipur
Ambamata, Udaipur
Udaipur
RAJASTHAN
313001
India 
Phone  9460353407  
Fax    
Email  bairwaboss75@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Gulab Chand Bairwa 
Designation  Professor and HOD 
Affiliation  Madan Mohan Malviya Government Ayurvedic College, Udaipur 
Address  PG department of Shalakya Tantra, Madan Mohan Malviya Government Ayurvedic College, Udaipur
Ambamata, Udaipur

RAJASTHAN
313001
India 
Phone  9460353407  
Fax    
Email  bairwaboss75@gmail.com  
 
Source of Monetary or Material Support  
Madan Mohan Malviya Government Ayurvedic College, Ambamata, Udaipur, Rajasthan, India, pin code: 313001 
 
Primary Sponsor  
Name  Madan Mohan Malviya Government Ayurveda College Udaipur 
Address  Madan Mohan Malviya Government Ayurveda College and Hospital, Ambamata, Udaipur, Rajasthan, India, Pin code : 313001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Monika Mittal  Madan Mohan Malviya Government Ayurveda College, Udaipur  OPD no. 9 and 10, PG department of Shalakya Tantra, Madan Mohan Malviya Govt. Ayurved College and Hospital, Ambamata, Udaipur
Udaipur
RAJASTHAN 
8949721283

monikamittal1997@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee M.M.M. Govt. Ayurved College, Udaipur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:G40-G47||Episodic and paroxysmal disorders. Ayurveda Condition: ARDHAVABEDAKAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Rasnadi Kwath, Reference: Brihata Nighantu Ratnakar, Volume 6, page no. 406, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Pathyadi Kwath, Reference: Sharangdhar Samhita, Madhyam Khand, Chapter 2, Shloka 143-145, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  i) Patients willing for trial and ready to given written consent.
ii) Age between 18 to 60 years.
iii) Patient of any sex.
iv) Chronicity not exceedingly more than five years.
 
 
ExclusionCriteria 
Details  i) Age below 18 or more than 60 years.
ii) Patients of migraine who are taking other preventive treatment.
iii) Patients who are suffering from other chronic diseases like DM, HTN, etc.
iv) Patients who are suffering from secondary headache of meningitis, brain tumor, encephalitis or having referred pain on one half of the head due to disorders of eye, ear, nose, throat, etc.
v) Evidence of significantly active psychiatric disease including manic depressive illness, schizophrenia, generalized anxiety disorder, OCD, and personality disorder.
vi) Women who are pregnant or nursing.
vii) Patients with excessive alcoholic, opiate, barbiturate use and have history of drug dependence or drug abuse.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Effectiveness of Treatment in Improving Sign and Symptoms of disease  45 days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in Associated Sign and Symptoms of disease  45 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   22/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This is a clinical trial to compare efficacy of Pathyadi Kwath and Rasnadi Kwath in the management of Ardhavbhedak with special reference to Migraine. In this trial 2 groups each of 30 patients will be selected. Group A will be administered with Pathyadi Kwath 40ml BD with anupana of gud. Group B will be administered with Rasnadi Kwath 40ml BD.

 
Close